venBio Select Advisor »

Cerevel Therapeutics Hldng I shares owned by venBio Select Advisor

Quarter-by-quarter ownership of Cerevel Therapeutics Hldng I (CERE) shares owned by venBio Select Advisor from 13F filings

Historical chart of venBio Select Advisor investment in Cerevel Therapeutics Hldng I

Tip: Access up to 7 years of quarterly data

All positions including Cerevel Therapeutics Hldng I held by venBio Select Advisor consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cerevel Therapeutics Hldng I by venBio Select Advisor

Quarter filed Position value Share count Share price at filing
2024-03-31 $319M 7.6M 42.27
2023-12-31 $320M 7.6M 42.40
2023-09-30 $21M 956k 21.83

More positions owned by venBio Select Advisor

United Therapeutics Corp Common (UTHR)
Apellis Pharmaceuticals Common (APLS)
Ascendis Pharma Sponsored ADR (ASND)
Sarepta Therapeutics Common (SRPT)
Madrigal Pharmaceuticals Common (MDGL)
Argenx Se Sponsored ADR (ARGX)
Krystal Biotech Common (KRYS)
Spdr Series Trust - S&p Biotech Etf (XBI)
Biomarin Pharmaceutical Common (BMRN)
Amicus Therapeutics Common (FOLD)
Cerevel Therapeutics Hldng Common (CERE)
Viking Therapeutics Common (VKTX)
Arrowhead Pharmaceuticals Common (ARWR)
Xenon Pharmaceuticals Common (XENE)
Alpine Immune Sciences Common

View all positions for venBio Select Advisor

Top funds holding Cerevel Therapeutics Hldng I

Bain Capital Investors
Vanguard Group
BlackRock
State Street Corporation
Alliancebernstein
Qube Research & Technologies
Farallon Capital Management
Melqart Asset Management
Goldman Sachs Group
P. Schoenfeld Asset Management
Water Island Capital
Squarepoint Ops
Balyasny Asset Management
Hsbc Holdings
Morgan Stanley

View all funds holding Cerevel Therapeutics Hldng I